Kiran Chinnalla and Julian Backhouse explain why automation for labelling in pharma can help the industry to remain compliant in the face of regulatory changes.

In this webinar we will be discussing the results of our latest study where we evaluated the ruggedness, repeatability and specificity of commercially available rFC products, as well as our own recombinant product in development, against a large panel of endotoxins.

Researchers have shown that sublimation tests should be conducted if new components are added to the freeze-drying process of HPAPIs.

A Phase III clinical trial to evaluate J&J’s COVID-19 vaccine in multiple countries has enrolled its first patients.

A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.